4//SEC Filing
Sukhtian Faisal Ghiath 4
Accession 0001209191-20-053872
CIK 0001649989other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:46 PM ET
Size
8.4 KB
Accession
0001209191-20-053872
Insider Transaction Report
Form 4
Sukhtian Faisal Ghiath
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-10-05$0.51/sh+151,721$78,000→ 151,721 totalExercise: $0.71Exp: 2030-10-05→ Common Stock (151,721 underlying) - Award
Stock Option (Right to Buy)
2020-10-01+296,352→ 296,352 totalExercise: $0.71Exp: 2030-10-01→ Common Stock (296,352 underlying)
Footnotes (2)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in full on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.
- [F2]The options were granted under the 2015 Plan in lieu of $78,000 cash fees payable under the Issuers's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001716033
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 6:46 PM ET
- Size
- 8.4 KB